[Federal Register Volume 64, Number 239 (Tuesday, December 14, 1999)]
[Notices]
[Page 69798]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-32329]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Biotechnology Research and Development 
Corporation (``BRDC'')

    Notice is hereby given that, on August 2, 1999, pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Biotechnology Research and 
Development Corporation (``BRDC'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership status. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances. Specifically, Baxter Healthcare 
Corporation, Round Lake, IL has been added as a party to this venture. 
Also, Bernard Technologies, Inc., Chicago, IL has been dropped as a 
party to this venture.
    On June 11, 1999, BRDC issued to Baxter Healthcare Corporation 
(``Baxter'') and Baxter purchased from BRDC, 746\2/3\ shares of common 
stock, without par value, of BRDC. Simultaneously, with the issuance 
and purchase of the shares of the common stock, BRDC and Baxter entered 
into an Agreement to be Bound by BRDC Master Agreement whereby Baxter 
agreed to be bound by the terms and conditions of the BRDC Master 
Agreement effective as of June 10, 1998, by and among BRDC and its 
common stockholders. Baxter has the rights set forth in the BRDC Master 
Agreement in all project technology made, discovered, conceived, 
developed, learned or acquired by or on behalf of BRDC in connection 
with, or arising out of, or as the result of, a research project in 
existence while Baxter is a common stockholder of BRDC.
    Effective April 30, 1998, the Cooperative Research Agreement 
between BRDC and Bernard Technologies expired. Bernard Technologies was 
no longer a cooperative researcher with BRDC, effective May 1, 1998.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and Biotechnology Research and 
Development Corporation (``BRDC'') intends to file additional written 
notification disclosing all changes in membership.
    On April 13, 1988, Biotechnology Research and Development 
Corporation (``BRDC'') filed its original notification pursuant to 
section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to Section 6(b) of the Act on May 12, 
1988 (53 FR 16919).
    The last notification was filed with the Department on November 5, 
1998. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on January 29, 1999 (64 FR 4704).
Constance K. Robinson,
Director of Operations Antitrust Division.
[FR Doc. 99-32329 Filed 12-13-99; 8:45 am]
BILLING CODE 4410-11-M